Michele Adeleye

Ad-eh-layManaging Director
New York
About

Michele Adeleye has two decades of in-house legal leadership experience in a global Fortune 50 pharmaceutical company supporting litigation, emerging markets, global product support and digital teams. In her most immediate previous role, she was responsible for helping the pharmaceutical company drive intentional artificial intelligence (AI) transformation efforts and provided both leadership and training to the lawyers. She supported an in-house build team on the company's first in-the-wild launch of a GenAI product and provided regular advice, counseling and training to numerous build teams for the business. Now, she brings that expertise into DLA Piper and helps companies articulate how and why they are reimagining legal work to help clients understand how PiperAI products and services can address their needs. Any process can be automated but that does not mean the work has been reimagined. In order to be successful in an AI transformation in any sector, both the work and the flow have to be reimagined.

"I listen to the problem and seek to understand the culture, the goals and the pain points of a legal department. I extrapolate the why from the how to continually focus on the ultimate stakeholder benefit."

 Michele is a lawyer but is not practicing law in her role as Managing Director.

Areas of FocusArtificial Intelligence and Data AnalyticsLife Sciences
Bar AdmissionsNew York

EXPERIENCE

Michele has fluency in a broad spectrum of legal issues faced by pharmaceutical companies, including healthcare compliance, advertising and promotion, emerging market retail strategies, med tech and AI risks and governance.

Pro Bono

Michele spent many years in her previous role as the lead for the Street Law Program providing experiential education and mentorship for inner city high school students.

Education
  • J.D., Chicago-Kent College of Law
  • B.A., Northwestern University

Seminars

  • "The Freedom to incorporate AI into the ADR process," CPR Institute, March 2024
  • "The legal challenges raised by the rapid expansion of artificial intelligence," DLA Piper Life Sciences Summit, October 2023
  • ACI Life Sciences AI Summit, February 2023
  • Drug & Medical Device Virtual Seminar, DRI, April 2021 
  • "Beyond the Doctor's Office: When Technology Expands the Reach of Patient Care," Drug & Medical Device Seminar, DRI, May 2020 

Prior Experience

Michele has a broad legal background, having started her career as a litigator in private practice and working in-house at another pharmaceutical company as a litigator prior to moving to her immediate past role in a Fortune 50 pharmaceutical company.

Teaching Experience

Michele has experience as an adjunct professor teaching negligence law to nursing students.

CallvCardLinkedInPrint

Connect

Phone

+1 212 776 3921
(Work, New York)